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Ninety percent of Americans consume less than the estimated average requirements of dietary
vitamin E (vitE). Severe vitE deficiency due to genetic mutations in the tocopherol transfer protein
(TTPA) in humans results in ataxia with vitE deficiency (AVED), with proprioceptive deficits and so-
matosensory degeneration arising from dorsal root ganglia neurons (DRGNs). Single-cell RNA-
sequencing of DRGNswas performed in Ttpa/mice, an establishedmodel of AVED. In stark contrast
to expected changes in proprioceptive neurons, Ttpa/ DRGNs showed marked upregulation of
voltage-gated Ca2+ and K+ channels in mechanosensitive, tyrosine-hydroxylase positive (TH+)
DRGNs. The ensuing significant conductance changes resulted in reduced excitability in mechanosen-
sitive Ttpa/ DRGNs. A highly supplemented vitE diet (600 mg dl-a-tocopheryl acetate/kg diet)
prevented the cellular and molecular alterations and improved mechanosensation. VitE deficiency
profoundly alters the molecular signature and functional properties of mechanosensitive TH+
DRGN, representing an intriguing shift of the prevailing paradigm from proprioception to mechanical
sensation.
INTRODUCTION
A mere 10% of the adult American population consume the estimated average requirements (EARs) of
vitamin E (vitE) (15 mg/day a-tocopherol [a-TOH]) (Fulgoni et al., 2011; Institute of Medicine, 2000; Maras
et al., 2004). Severe vitE deficiency stemming from liver diseases, extensive intestinal resections, and the
inherited disease of vitE deficiency termed ‘‘ataxia with vitE deficiency’’ (AVED) result in profound ataxia
(Muller, 2010). Prevailing functions of vitE have been ascribed to the maintenance of typical neurologic
structure and function. Despite identification of vitE as an essential food nutrient (Brigelius-Flohe and
Traber, 1999), the molecular, cellular, and functional mechanisms of vitE remain debated. There is exten-
sive evidence supporting the role of vitE, specifically a-tocopherol (a-TOH), as a lipid-soluble antioxidant
in vitro (Niki, 2014) and in vivo (Choi et al., 2015; McDougall et al., 2017), and this has been suggested to be
the primary functional mechanism of biologic activity (Traber and Atkinson, 2007). Besides this well-estab-
lished role as an inhibitor of lipid peroxidation, other non-antioxidant properties of a-TOH have been iden-
tified, including transcriptional regulation and cell signaling (Azzi, 2018).
AVED results from mutations in the a-tocopherol transfer protein gene (TTPA) (Gotoda et al., 1995; Yo-
kota et al., 1996). Phenotypic variability is due the location of the genetic mutation within TTPA, the
amount of vitE in the daily diet, and the time of initiation and dosage of vitE supplementation (Bellayou
et al., 2009; Di Donato et al., 2010). Most patients demonstrate symptoms of AVED between 4 and 18
years of age (Cavalier et al., 1998; Gotoda et al., 1995; Schuelke, 1993). Patients with AVED exhibit ataxia,
areflexia, decreased fine touch, and vibration discrimination (Gotoda et al., 1995; Schuelke, 1993). Histo-
logic hallmarks of AVED include axonal swellings within the dorsal column medial lemniscus pathway, the
sensory pathway that conveys sensations of fine touch vibration, two-point discrimination, and proprio-
ception from the skin and joints. Of note, lesions in the gracile system of the medulla oblongata are also
features of physiologic neuroaxonal aging across many species (Bridge et al., 2009). Chronic vitE, specif-
ically a-TOH, deficiency slowly accelerates brain lipid peroxidation and results in cognitive impairment in
mice (Fukui et al., 2015) and zebrafish (McDougall et al., 2017). These deficits can be partially restored by
vitE supplementation, in the form of a-TOH. Indeed, early a-TOH supplementation in patients with AVED
may suppress severe disease symptoms by unknown mechanisms (Aparicio et al., 2001).720 iScience 21, 720–735, November 22, 2019 ª 2019 The Author(s).
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Ttpa/mice represent an accepted model that recapitulates the phenotype of AVED, with ataxia and his-
tologic lesions, including reduction of myelinated fibers in the gracile fasciculus and chromatolysis of neu-
rons within the nucleus gracilis, as early as 6 months of age (Finno et al., 2018). By 17 months of age, dimin-
ished dendritic branching of Purkinje neurons within the cerebellum is evident (Ulatowski et al., 2014). The
affected somatosensory tracts originate in the dorsal root ganglia (DRG), with apoptosis of DRG neurons
(DRGNs) evident by 12 months of age (Finno et al., 2018). Therefore, it has been suggested that the most
pronounced neurologic deficit in Ttpa/mice is loss of proprioception. This proprioceptive loss and asso-
ciated pathology in the spinal cord and cerebellum can be prevented by supplementation of Ttpa/mice
at weaning with 17x the amount of dl-a-tocopheryl acetate (600 mg/kg feed) (Finno et al., 2018). These
studies demonstrate that the interaction of genotype, dietary vitE concentration, and time point in post-
natal development are crucial to the development of the neurologic phenotype.
To investigate the underlying mechanisms of functional alterations with vitE deficiency, single-cell RNA-
sequencing (scRNA-seq) was performed within the DRG of Ttpa/ mice. We hypothesized that the
most profound transcriptional dysregulation with vitE deficiency would occur in large-diameter myelinated
proprioceptive DRGNs. Therefore, we sought to (1) define the transcriptional dysregulation within DRGN
subpopulations in Ttpa/mice and (2) identify alterations inmembrane electrical properties within the tar-
geted DRGN subpopulations of Ttpa/ mice.RESULTS
Single-Cell RNA-Sequencing Defines Specific DRGN Subpopulations
To determine the molecular mechanisms leading to sensory deficits in vitE-deficient DRGNs, scRNA-seq
was performed on neuronal cells collected from the DRG (between cervical [C1] and lumbar [L6] vertebrae)
of mice in three experimental groups: (1) Ttpa+/+ on a basal vitE diet (vitE+; WT), (2) Ttpa/ on vitE-defi-
cient diet (DEF), and (3) Ttpa/ on vitE-supplemented diet (SUPP) at 6 months of age (Table S1; see
Methods for dietary vitE levels). We have previously identified clinicohistologic evidence of the ataxic
phenotype by 6 months of age and completed whole tissue transcriptomic profiling of spinal cord and cer-
ebellum at this time point (Finno et al., 2018). In that study, we identified only minor differences between
Ttpa/mice maintained on a basal diet (i.e. 35 mg of dl-a-tocopheryl acetate/kg feed) and Ttpa/mice
on a vitE-deficient diet (DEF; <10 mg of dl-a-tocopheryl acetate/kg feed). Instead, a highly supplemented
vitE diet (SUPP; 600 mg of dl-a-tocopheryl acetate/kg feed) was required to prevent the AVED phenotype.
Therefore, in the current study, we focused our comparisons on DEF vs. WT and DEF vs. SUPP mice. Con-
trasts included (1) WT vs. DEF, to determine gene expression changes associated with severe vitE defi-
ciency in DRGNs; (2) SUPP vs. DEF to determine the biologic mechanisms whereby the clinicopathologic
AVED phenotype is prevented; and (3) SUPP vs. WT to identify any remaining dysregulated pathways
following high-dose vitE supplementation in Ttpa/ mice. As high-dose vitE supplementation does not
restore brain a-TOH to WT concentrations (Finno et al., 2018; Yokota et al., 2001), we postulated that
any gene dysregulation within the SUPP vs. WT group may provide insight into this phenomenon.
ScRNA-seq was performed on an average of 3,614G 470 DRGN from two replicate mice per group, with a
total of 382 million (M) reads generated (17,862G 2,625 reads/cell). Approximately 66.5% of reads mapped
to the murine transcriptome, similar to previous reports (Usoskin et al., 2015), and an average of 1,788 G
283 genes detected per cell, with no difference between experimental groups (Figure S1).
Unsupervised single-cell transcriptome profiling identified 14 initial subpopulations in all mice, using gene
profiles as previously reported (Figures 1A and S2A) (Usoskin et al., 2015; Li et al., 2016). Based on further
evaluation of subpopulations 0 and 2, both clusters appeared to contain peptidergic neurons and were,
therefore, merged into cluster 0.2 (Figure S2B). The top transcripts in each subpopulation are provided
in Table S2. A t-distributed stochastic neighbor embedding (t-SNE) plot identified a small number of
neuronal cells that could not be classified based on previously reported gene profiles (Figure S2A). This
cluster was labeled as ‘‘Unassigned.’’ Each DRG subpopulation set contained differentially expressed
genes characteristic for that cluster. These clusters were classified as PEP1, PEP2, NP1, NP2, NP2-2,
NP3, NF1, NF2, NF3, NF4-5, TH1, and TH2 as previously described (Usoskin et al., 2015) and ‘‘Unassigned’’
for the unassigned cluster (Table S2). There were no significant differences in cell count per neuronal cluster
across experimental groups (p> 0.05 in each subpopulation) (Table S1). A distinct population of microglial
cells based on previously reported markers was not identified (Figure 1A). Although previous studies have
identified outliers or cells with unresolved identity, we further evaluated the ‘‘Unassigned’’ DRGNiScience 21, 720–735, November 22, 2019 721
Figure 1. An Overall Increase in the Number of Differentially Expressed Transcripts across All DRGN
Subpopulations with a-TOH Deficiency
(A) A t-distributed stochastic neighbor embedding (t-SNE) plot of merged datasets of the six experimental mice to define
neuronal subpopulations clusters. Thirteen clusters were identified based on previously reported gene expression
profiles (Li et al., 2016; Usoskin et al., 2015). The ‘‘NP2-2’’ subgroup contained some genes representative of the NP2
cluster but was distinct from the NP2 cluster and has been previously characterized (Usoskin et al., 2015; Li et al., 2016).
(B) An increasing number of significantly (PFDR<0.05) differentially expressed transcripts (DETs) was identified in each
DRGN subpopulation with increasing contrasts of vitE deficiency (i.e. SUPP vs. DEF > WT vs. DEF > SUPP vs. WT).
(C and D) (C) The two most commonly dysregulated transcripts across DRGN subpopulations were carbonic anhydrase 8
(Car8), which was significantly downregulated in 10/13 DRG clusters with vitE deficiency (SUPP vs. DEF), and (D) the
lineage-specific transcription factor Runx3, which was significantly upregulated in 10/13 DRG clusters with vitE deficiency
(SUPP vs. DEF). p values were adjusted by a false discovery rate of 0.05 and log-transformed. Significance was set at
PFDR<0.05, corresponding to a –log Padjusted>1.3 (red line). NF = neurofilament, NP = non-peptidergic, PEP = peptidergic,
TH = tyrosine hydroxylase, UNKNOWN = unknown cluster, n = 2 mice per group with ~3,600 cells/mouse profiled.subpopulation using the top 15 transcripts defining this cluster (Figure S2A, Table S2). Two of themost spe-
cific transcripts representing this cluster, forkhead box protein transcription factor 2 (Foxp2) and olfacto-
medin 3 (Olfm3), have been previously identified in DRG, primarily in postnatal mice through P14 (Jia
et al., 2018; Nakaya et al., 2012). However, these transcripts are also present in adult brain (Ferland
et al., 2003; Nakaya et al., 2012; Saunders et al., 2018). Therefore, this subset of neurons most likely repre-
sents the small number of remaining developmental neurons undergoing axonal growth.
An Increasing Number of Dysregulated Transcripts with Increasing vitE Deficiency
Within each neuronal cluster, dysregulated transcripts were identified between WT vs. DEF, SUPP vs. WT,
and SUPP vs. DEF. For each cell subpopulation, at least two-fold dysregulated (i.e. up- or downregulated at
PFDR<0.05) transcripts were identified between vitE treatment groups (i.e. SUPP vs. DEF >> WT vs. DEF >
SUPP vs WT) (Figure 1B, Tables S3 andS4). The greatest degree of dysregulation in the SUPP vs. DEF group
was apparent in the NP1 and TH2 subpopulations (Figure 1B).
Top Dysregulated Transcripts across the Majority of DRG Subpopulations: Car8 and Runx3
WhenWT and SUPP were compared with the DEF groups, carbonic anhydrase 8 (Car8), encoding for a pro-
tein that inhibits inositol trisphosphate receptor 1 (IP3R1) (Zhuang et al., 2015), was significantly (PFDR<0.05)
downregulated in 10/13 DRG clusters (Figure 1C). In particular, Car8 was the top downregulated transcript722 iScience 21, 720–735, November 22, 2019
Figure 2. Upregulation Intermediate Voltage-Gated Ca2+ and K+ Channels in TH+ DRGNs with vitE Deficiency
Heatmaps, plotted by –logPadjusted, comparing the degree of upregulation for R-type intermediate voltage-gated Ca
2+,
Cacna1e, and Ca2+-activated K+ channel beta subunits channels, Kcnmb1 and Kcnmb2, in DRGN subpopulations with
vitE deficiency. Contrast A = SUPP vs. WT, contrast B = WT vs. DEF, contrast C = SUPP vs DEF. Cacna1e= Cav2.3
intermediate voltage-activated Ca2+ channel, Kcnmb = Potassium large conductance calcium-activated channel,
subfamily M, beta.with vitE deficiency in the four neurofilament subgroups (NF1, NF2, NF3, and NF4/5). Car8 was downregu-
lated in these subgroups even in the SUPP vs. WT contrast (Figure 1C). The lineage-specific transcription
factor Runx3 was significantly (PFDR<0.05) upregulated in 10/13 DRG clusters when comparing WT and
SUPP vs. DEF groups, especially within NP3 and TH2 (Figure 1D). Even within the SUPP vs. WT contrast,
Runx3 remained significantly upregulated in 8/13 DRG subpopulations, including NP3 and TH2 (Figure 1D).
As Car8 is the primary inhibitor of IP3R1 (Hirasawa et al., 2007; Hirota et al., 2003) and transcription of Car8
was significantly downregulated with vitE deficiency, we postulated that IP3R1 signaling might be affected
by the level a-TOH supplementation. In DEF mice, a pronounced decrease in IP3R1 was apparent in TH+
DRGNs, whereas protein levels appeared increased in SUPP mice (Figure S3A). Similarly, Car8 was
increased in TH+ DRGNs in the SUPP group (Figure S3B).
Profound Upregulation of Voltage-Gated Ca2+ and K+ Channels in TH+ DRGNs
Modulation of Ca2+ channel activities mediate changes in neuronal plasticity and, when upregulated, promote
neurodegeneration (Chilton, 2006). Transcripts associated with both ligand-gated and voltage-gated Ca2+ and
K+ channels were evaluated across genotype and vitE diet groups in our scRNA-seq dataset (Table S5). When
comparing SUPP vs. DEF groups, of the voltage-activated Ca2+ channels expressed in DRGNs, intermediate-
voltage Cav2.3 (Cacna1e; TH1 PFDR = 1.51 x 10
8, TH2 PFDR = 1.29 x 10
11) channel was most notably upregu-
lated in TH+ DRGNs (Figure 2A). High-voltage-activated P-type Ca2+ channel, Cacna1a, was not significantly
altered in any DRGN subpopulation, whereas N-type Ca2+ channel, Cacna1b, was only upregulated in the
NP1 DRGN subpopulation of the SUPP vs. DEF groups (PFDR = 0.001) (Table S5). When evaluating K
+ channel
transcripts significantly (PFDR< 0.05) upregulated in the SUPP vs. DEF groups, the most commonly affected
DRGN subpopulations for K+ voltage-gated channel transcript upregulation were TH+ (Table S5). In particular,
regulatory subunits of the large-conductance Ca2+-activated channel subfamily M (Kcnmb1; TH1 PFDR = 0.009,
TH2 PFDR = 1.68 x 10
4 andKcnmb2; TH1 PFDR = 0.017, TH2 PFDR = 5.20 x 10
5) were upregulated in TH+DRGNs
(Figure 2B). Although a few of the transcripts encoding voltage-gated K+ channels were upregulated in TH+
DRGNs, most transcripts in this family were upregulated in the non-peptidergic DRGNs (Table S5).
Increase in Cacna1e and Kcnmb2 with vitE Deficiency in TH+ DRG
To confirm that Cav2.3 (Cacna1e) and regulatory subunits Kcnmb1 and Kcnmb2 were indeed upregulated,
we further evaluated mRNA and protein levels of Cacna1e and Kcnmb2. In DEF mice, there was aiScience 21, 720–735, November 22, 2019 723
Figure 3. Increase in Cacna1e and Kcnmb2 with vitE Deficiency in TH+ DRG
(A–D) Green: Th, Blue: DAPI nuclei, Red: Cacna1e [(A) mRNA, (B) protein] and Kcnmb2 [(C) mRNA, (D) protein]. White box inset magnified in the last column.
Fluorescent immunohistochemistry from 4-month WT, DEF, and SUPP mice, n = 1–2 per group. Scale bars represent 10 mm (TH, Cacna1e, Kcnbm2, and
merge) and 3 mm (enlarged).
(E) Quantification of mRNA using RNAscope for Cacna1e and Kcnmb2. Mean G SD, N = 8 counts per experimental group, one-way ANOVA, or Kruskal-
Wallis. Scale bars represent 10 mm (TH, Cacna1e, Kcnbm2, and merge) and 3 mm (enlarged).
(F) Von Frey assay, demonstrating a significant increase in sensitivity (i.e. lower Dixon’s score) in the SUPP vs. DEF mice. Mean G SD, N = 8–22 per group,
one-way ANOVA, ****p< 0.0001, **p< 0.01, *p< 0.05.pronounced increase in Cacna1e and Kcnmb2 in TH+ DRGNs at the level of both mRNA (Figures 3A, 3C,
and 3E) and respective proteins (Figures 3B and 3D).Supplementation with High-Dose a-TOH Increased Mechanical Sensitivity in Ttpa/Mice
The von Frey filament assay was performed as previously described (Martinov et al., 2013). SUPP mice had
significantly increased mechanical sensitivity compared with DEF diet (Padjusted = 0.007, Figure 3F).Altered Excitability of DEF Small-Diameter DRGNs
To understand the etiology and mechanisms of DRG neuronal responses, sensory deficits, and degenera-
tion in AVED as shown in Ttpa/mice (Finno et al., 2018; Yokota et al., 2001), we focused on the changes in
membrane electrical properties. First, we focused on identifying small-diameter mechanosensitive DRGNs.
We applied displacement-clamp at DRGN cell-bodies. Using a holding potential of 70 mV, mechanical
displacement of the small-diameter DRGN cell body evoked inward currents (Figure 4A, inset shows traces
from WT DRGN). The mechanically activated (MA) current (IMA) had amplitudes ranging from 75 to 500 pA
(n = 11; Figure 4A). The displacement-response relationships from data fromWT DRGNs were fitted with a
single Boltzmann function with half-maximal activation displacement (X1/2) and slope factor of 1.1G 0.1 mm
and 0.3 G 0.1 mm (n = 11; Figure 4A). Similar data from DEF DRGNs for X1/2 and slope factor were 1.5 G
0.1 mm and 0.4 G 0.1 mm (n = 7). Unpaired ttest comparison shows significant differences in the X1/2 (p =
0.016) but not the slope factor (p = 0.51) between the WT and DEF DRGNs. The rightward shift in the
displacement-response relations in the DEF DRGNs suggest a decrease in mechanical sensitivity.
Three functional classes of neurons were then assessed based on their evoked spike frequency adaptation
kinetics, defined as fast (eliciting 1–2 APs for 0.5-s suprathreshold current injection), medium (4–6 APs),
and slow (>10 APs) adapting neurons. We first compared WT with DEF DRGNs. On average, the input re-
sistances of the three classes of neurons in WT were 2-fold greater than the DEF neurons. Figures 4B and724 iScience 21, 720–735, November 22, 2019
Figure 4. Membrane Properties of Small-Diameter Dorsal Root Ganglion Neurons (DRGNs) from WT and DEF
Mice
Current-clamp recordings were performed on DRGNs 6-month-old mice. Membrane input resistance (Ri) was determined
by evaluating membrane voltage changes in response to negative and positive current injection. The ohmic relations
were fitted with linear regression and the Ri derived from the slope.
(A) Representative traces of displacement-clamp currents recorded using CsCl/NMG-based pipette solution in response
to ~250-ms mechanical displacement steps of ~0.42 mm to WT small-diameter DRGN (shown as inset). DRGNs were held
at 70 mV. Summary data of displacement-response relationship of mechanically activated (MA) currents (IMA)
represented as the I/Imax or open channel probability (Po) against displacement (X) fitted with single Boltzmann function.
Data from WT DRGNs (shown in black symbols and fitted with sigmoidal curve in black) and the one-half maximum
displacements (X1/2) are 1.1G 0.1 mm and 0.3G 0.1 mm (n = 11). Data from DEF DRGNs (shown in blue symbols and fitted
with sigmoidal curve in blue) and the one-half maximum displacements (X1/2) are 1.5G 0.1 mm and 0.4G 0.1 mm (n = 7).
(B) Among the small-diameter neurons, there were three distinct classes: fast, medium, and slow adapting. Exemplary
plots from fast-adapting DRGNs from WT mice (shown in black, mean Ri in MU; 100 G 6; n = 15), and in DEF (shown in
blue, mean Ri in MU; 45G 5; n = 17: p< 0.0001). The inset is an example of data used to generate the plots. For medium-
adapting neurons the Ri (in MW) were as follows: WT (306G 23; n = 9) and DEF (162G 29; n = 11: p = 0.0014). For slow-
adapting neurons the Ri were WT (626 G 47; n = 13) and DEF (395 G 38; n = 11: p = 0.0012).
(C) Brief (~5 ms) stepwise positive current was injected to elicit subthreshold (shown in different color codes) and
threshold depolarization (WT in black and DEF in blue). The threshold currents are indicated. The threshold voltage was
determined, using a dV/dt loop plot (inset, right).
(D and E) Typical voltage response from slow-adapting DRGNs recorded from WT and DEF mice.
(F and G) Action potentials generated using varying pulse durations from fast-adapting DRGNs in WT (F) and DEF (G)
mice.
(H) Plots of the relations between threshold potential and pulse duration inWT (in black) and DEF (in blue) mice. The insets
show the dV/dt versus membrane potential (V) loops used to determine the thresholds.4C summarize exemplary steady-state input resistances (Ri, in MU), of the WT (black; 100G 6; n = 15), with
0.33 nA required to elicit an AP and DEF (blue; 45G 5; n =17), with 0.73 nA being the AP threshold for
fast-adapting DRGNs. For medium-adapting neurons, the Ri were WT (306 G 23; n = 9) and DEF (162 G
29, = 11), and for slow-adapting neurons the Ri were WT (626 G 47; n = 13) and DEF (395 G 38; n = 11).
The intrinsic membrane properties of the small-diameter DRGNs suggested that membrane excitability
was reduced in DEF mice. In agreement with this assertion, DEF slow-adapting DRGNs showed profoundiScience 21, 720–735, November 22, 2019 725
attenuation in spike activity in response to current injection compared with WT DRGNs (Figures 4D and4E).
AP thresholds for fast-adapting DRGNs were determined by calculating dV/dt, as illustrated in Figure 4C
(right panel), and the sensitivity of neurons were tested using the indicated pulse duration. For WT DRGNs,
with increasing pulse duration, the threshold voltage amplitude declined in a monotonic fashion. However,
for DEF DRGNs, the threshold voltage had a biphasic response relative to pulse duration (Figures 4F–4H).
Increased K+ and Ca2+ Density in DEF Small-Diameter DRGNs
The underlying conductances responsible for the reduced Ri and membrane excitability in the small-diameter
Ttpa/DRGNs were examined in the voltage-clamp configuration. Ca2+ and K+ currents were isolated under
conditions where other ion channel conductances were suppressed. The rationale for focusing on these Ca2+
andK+ conductances stemmed from the scRNAseq analyses (Figures 2 and 3).Whole-cell voltage-clampof the
small-diameter mechanosensitive DRGNs showed outward K+ currents with transient and sustained compo-
nents in both WT (Figure 5A, upper panel, black) and DEF (Figure 5A, lower panel, blue) mice in response to
varying voltage steps (110 to 40 mV) from a holding potential of 90 mV in 10-mV increments. The differ-
ence-current traces plotted in dashed lines (inset) provide the profile of the enhanced outward K+ current in
the DEFDRGNs. This difference in currents consisted ofmainly a sustained outward current. The total outward
K+ current density plotted as a function of voltage showed significant differences in current densities elicited at
30 to 40mVstepvoltages comparingdatabetweenWTandDEFmice (n=17; p<0.05, Figure 5B). Toexamine
Ca2+ currents, we suppressed outward K+ currents, by substituting pipette and bath K+ with NMDG+ and Cs+
(see Methods). Inward Na+ current contamination of Ca2+ currents was suppressed using TTX (1 mM) and by
partial substitution of bathNa+ with NMDG. Ca2+ currents were activated using90 and40mV holding volt-
ages, and varying step voltages were applied from120 to 40 mV. Ca2+ currents in DRGN consist of multiple
components: low- and high-voltage-activated currents (Boland and Dingledine, 1990; Wu and Pan, 2004). The
difference-current derived by subtracting current traces generated from 40 mV and that at 90 mV holding
potentials yielded mainly the transient and low-voltage activated components (Figures 5C and 5D). Summary
data from current-voltage relations show that the high-voltage-activated Ca2+ currents were enhanced in
DEF DRGNs (Figure 5E). As shown in the inset and illustrated in the current-voltage, rSNX-482 (500 nM), a
Cav2.3 (R-type) current-specific blocker (Xie et al., 2016), suppressed a component of the Ca
2+ current. Addi-
tionally, in three recordings from DEF DRGNs, in which rSNX-482 was applied in the bath solution, the
enhanced current was attenuated, suggesting the current was conducted by Cav2.3 channels (Catterall
et al., 2005; Xie et al., 2016).
Since high-dose vitE supplementation on DEF DRGN appeared to restore the molecular and cellular hall-
marks of vitE deficiency, we examined the membrane properties of small-diameter DRGNs in SUPP mice.
We examined sensitivity of SUPP DRGNs to mechanical displacements as described in Figure 4A. The
displacement-response relationships from data from SUPP DRGNs were fitted with a single Boltzmann
function (shown in green) with half-maximal activation displacement (X1/2) and slope factor of 1.09 G
0.1 mm and 0.3 G 0.1 mm (n = 6; Figure 6A). We superimposed data from WT (in black) and DEF (in blue)
DRGNs for comparison. A one-way ANOVA was performed to compare the X1/2 and the slope factor in
WT, DEF, and SUPP DRGNs displacement-response curves. There were significant differences at the p<
0.05 level for the three conditions (X1/2 F(2,21) = 6.088, p = 0.008). Post-hoc comparisons using the Tukey
HSD test indicated that data from WT and DEF (p = 0.011) as well as DEF and SUPP (p = 0.024) are signif-
icantly different. There was no significant difference between WT and SUPP. Additionally, there were no
significant differences in the slope factor in the three experimental conditions.
Excitability of SUPP Small-Diameter DRGNs
For SUPP mice, fast-adapting DRGNs had a mean Ri 115G 9 MU (n = 11) (Figure 6B, shown with green sym-
bols and line). The Ri between WT (in black line), DEF (in blue line), and DRGNs (Figure 4B) is replotted for
comparison. There were significant differences at the p< 0.05 level for the three conditions (F(2,40) = 174.7,
p = 0.001). Post-hoc comparisons using the Tukey HSD test indicated that Ri from WT vs. DEF (p = 0.001),
WT vs. SUPP (p = 0.001), and DEF vs. SUPP (p = 0.001) are significantly different. Similar to WT DRGNs, as
the pulse duration was prolonged, the threshold voltage amplitude declined (Figure 6C). However, the
apparent preventative effects of vitE supplementation were not visibly seen in the slow-adapting small-
diameter DRGNs. Compared with WT DRGNs, the slow-adapting neurons in SUPP did not recover fully
despite vitE supplementation (Figure 6D). We examined whole-cell onward K+ currents by applying depo-
larizing voltage steps from130 to 30mV (DV = 10mV), from a holding potential of90mV in SUPP DRGNs
(Figure 6E). The steady-state outward K+ currents normalized to individual membrane capacitance (Cm)726 iScience 21, 720–735, November 22, 2019
Figure 5. Increased K+ and Ca2+ Current Density in DEF versus WT DRGNs
(A)Whole-cell onward K+ currents were elicited using depolarizing steps from 110 to 40 mV (DV = 10 mV). The tail
currents were at40 mV. Current traces recorded fromWT and DEF DRGNs are shown in black and blue, respectively. To
obtain a profile of currents that are enhanced in DEF DRGNs, we determined the ‘‘difference currents’’ between DEF and
WT neurons at 70 and 40 mV step voltages (traces are plotted with dashed lines in inset).
(B) Summary of steady-state currents was normalized to individual membrane capacitance (Cm), from 6-month-old WT
mice (shown with black line and symbol) and DEF (shown with gray traces). Data were generated from 14 DRGNs
from each experimental group. The mean current densities (in pA/pF) in WT and DEF DRGNs at 0 mV step voltage were
26.1 G 2.6 and 39.9 G 2.8; n = 14, p = 0.0015.
(C and D) Inward Ca2+ currents recorded from a 12-pF DRGNs in WT (in black) and DEF (in blue) mice from 90 and
40 mV holding potentials. Currents were generated using voltage steps ranging from 110 to 40 mV. The difference-
current traces (90 mV) - (40 mV) are plotted in dashed lines as an inset.
(E) Peak Ca+ current density (I)-voltage (V) relation from data amassed from 12 DRGNs in each group. The current
densities generated from a holding voltage of 40 mV are plotted with WT in black and DEF in blue. The high-voltage
activated component of the Ca2+ current was enhanced in the DEF DRGNs. The peak current density (in pA/pF) for
currents elicited from a holding potential of 40 mV for WT DRGNs was 20.1 G 1.5 (n = 9) and for DEF DRGNs was
30.9G 2.5 (n = 9, p = 0.002). After application of 500 nM rSNX-482 to the DEF DRGNs the peak current density plummeted
to 12.6 G 1.2 (n = 6, p< 0.0001).(Figure 6F) showed that vitE supplementation is sufficient to restore the outward K+ current (plotted in
green and compared with themean data fromWT [in black] and DEF [in blue]) (see Figure 5B). For example,
the total outward current density elicited at 0 mV in SUPP DRGNs was 24.7G 2.9 pA/pF (n = 11). There were
significant differences at the p< 0.05 level for the three conditions; steady-state K+ current elicited at 0 mV
F(2,36)= 47.6, p = 0.001. Post-hoc comparisons using the Tukey HSD test indicated that WT vs. DEF (p =
0.001) and DEF vs. SUPP (p = 0.001) are significantly different. There is no significant difference between
WT vs. SUPP (p = 0.58). We recorded inward Ca2+ currents from 10-pF DRGNs in SUPP mice using 90
and 40 mV holding voltages. Currents were generated using voltage steps ranging from 120
to 40 mV (Figures 6G and 6H). The current-voltage relations generated at 90 mV and 40 mV holding
voltages are plotted, and the data suggest that vitE supplementation seemingly reversed the enhanced
high-voltage-activated Ca2+ current observed in DEF DRGNs (Figure 6I). Summary data from DEF DRGNs
in Figure 5E (in blue) is replotted for comparison.iScience 21, 720–735, November 22, 2019 727
Figure 6. Membrane Properties of Small-Diameter Dorsal Root Ganglion Neurons (DRGNs) from SUPP Mice
(A) Current-clamp recordings were performed on DRGNs 6-month-old mice supplemented with 600 mg dL-alpha-
tocopheryl/kg feed. Data were assessed from DRGNs with capacitance <15 pF. Membrane input resistance (Ri) was
determined by evaluating membrane voltage changes in response to negative and positive current injection.
(B) The ohmic relations were fitted with linear regression and the Ri derived from the slope. SUPP mice fast-adapting
DRGNs had a mean Ri of 115 G 9 MW (n = 11).
(C) Similar to WT DRGNs, as the pulse duration was prolonged, the threshold voltage declined.
(D) Typical voltage response from slow-adapting DRGNs recorded from SUPP mice. Compared with WT DRGNs, the
slow-adapting neurons in SUPP did not recover fully despite vitE supplementation.
(E)Whole-cell onward K+ currents were elicited using depolarizing steps from130 to 30 mV (DV = 10 mV), from a holding
potential of 90 mV. The tail currents were at 60 mV. Current traces recorded from SUPP DRGNs are shown.
(F) Summary of steady-state currents was normalized to individual membrane capacitance (Cm), from 6-month-old SUPP
mice. Data were generated from 15 DRGNs.
(G and H) Inward Ca2+ currents recorded from a 10-pF DRGNs in SUPP mice from 90 and 40 mV holding potentials.
Currents were generated using voltage steps ranging from 120 to 40 mV.
(I) The current-voltage relations generated at 90 mV and 40 mV holding potential is plotted. The I-V relations of Ca2+
currents from DEF DRGNs from Figure 5E is re-plotted in blue for comparison.Upregulation of Pro-apoptotic Transcripts with vitE Deficiency
Based on previous studies (Finno et al., 2018), evidence exists for increased apoptosis in the DRGNs with
vitE deficiency by 1 year of age in DEF mice. In both the TH2 (PFDR = 1.13 x 10
4) and NP1 (PFDR = 0.01)
DRGN subpopulations, apoptosis-inducing factor, mitochondrion-associated 3 (Aifm3), was upregulated
with vitE deficiency (WT vs. DEF and SUPP vs. DEF; Figure S4A). Additionally, tumor necrosis factor receptor
superfamily, member 21 (Tnfrsf21), which promotes apoptosis by release of cytochrome c from the mito-
chondria into the cytoplasm, was significantly upregulated in the NP2 (PFDR = 2 x 10
4) and TH2 (PFDR =
0.008) DRGN subpopulations (SUPP vs. DEF; Figure S4A). These results suggest that molecular signatures
of apoptosis, most pronounced in TH+ DRGNs, occur by 6 months of age in DEF mice.
To further investigate the pathways leading to apoptosis of DRGNs with vitE deficiency by 1 year of age
(Finno et al., 2018), and the potential preference for TH+ DRGNs, protein expression of total and cleaved728 iScience 21, 720–735, November 22, 2019
caspase 3, caspase 8, and caspase 9 was evaluated with both immunohistochemistry and Western blot an-
alyses in 4-month-old mice. There was no evidence of total caspase 3, caspase 8, or caspase 9 activation
(data not shown). However, a significant (p< 0.01) increase in cleaved caspase 3 and caspase 9, localized
to TH+ DRGNs, was apparent in DEF mice (Figures S4B and S4C). There was no evidence of cleaved cas-
pase 8 activation (Figure S4D).
Additional Transcript and Pathway Dysregulated with vitE Deficiency
In order to determine if the altered gene expression in the DEF DRGN was modulated by the vitE binding
proteins Ttpa (Kono et al., 2013) and tocopherol binding protein (Tap or Sec14l2) (Zingg, 2015), we inter-
rogated these transcripts in our dataset. Ttpa was not expressed in the DRGN dataset. Sec14l2 was ex-
pressed in DRGNs but only differentially expressed between SUPP vs. DEF in the NP1 subpopulation (up-
regulated in DEF group; PFDR = 0.004). Additionally, the scRNA-seq dataset was evaluated for genes
encoding enzymes that have been previously found to directly bind to vitE, including protein kinase C
(Prkca); PH domain and leucine-rich repeat protein phosphatase 2 (Phlpp2); cyclooxygenase-2 (Ptgs2);
and lipoxygenases 5, 12, and 15 (Alox5, Alox12, and Alox15) (Domijan et al., 2014; Zingg, 2015). Ptgs2,
Alox5, Alox12, and Alox15 were not expressed in DRGN and, although Phlpp2 was expressed, there
were no differences between experimental groups in any DRGN subpopulation. Prkca was significantly
downregulated in non-peptidergic DEF DRGN subpopulations (NP1, PFDR = 0.01; NP2, PFDR = 0.001;
and NP3, PFDR = 0.03) and upregulated in TH+ DRGN subpopulations (TH1, PFDR = 0.03 and TH2,
PFDR = 0.002) when comparing SUPP vs. DEF.
With severe vitE deficiency, degenerative axons are identified within the caudal medulla oblongata and spi-
nal cord with AVED (Yokota et al., 2000). Therefore, we interrogated our dataset for dysregulation of tran-
scripts associated with axonal guidance, synaptic plasticity, and myelination. When SUPP were compared
with the DEF groups, upregulation of associated transcripts was identified across DRGN subpopulations,
with most transcripts upregulated in TH2 DRGNs (Table S6). Myelin basic protein (Mbp) was upregulated in
4/13 SUPP vs. DEF DRGNs (Table S4) but was only downregulated in the TH2 subpopulation (PFDR = 0.004).
Because Ca2+ signaling triggers growth cone development during neurodevelopment (Chilton, 2006), tran-
scripts associated with Ca2+ binding were interrogated in our scRNA-seq dataset. Most Ca2+ binding tran-
scripts were most upregulated in TH+ DRGNs with increasing vitE deficiency (Figure S5A, contrast ‘‘C’’).
To further investigate the transcripts expressed among DRGN subtypes and across vitE diet groups,
pathway analyses were performed using Panther Pathway overrepresentation analysis (http://pantherdb.
org/). When WT and SUPP were compared with the DEF groups, the most commonly dysregulated path-
ways were upregulation of both the heterotrimeric G-protein signaling pathways Gia and Gsa (P00026) and
Gqa and Goa (P00027) (Figures S5B andS5C). Significant (PFDR< 0.05) upregulation of these two G-protein
signaling pathways was identified in 9/13 DRG clusters (Table S7, Figure S6). For many of these analyses, G-
protein coupled receptor (GPCR) pathways were also significantly (PFDR< 0.05) overrepresented (Table S7).
To further investigate the potential role of enhanced G-protein signaling with vitE deficiency in specific
DRGN subpopulations, specific somatosensory genes were evaluated, including G-coupled receptors
(GPCRs) and the transient receptor potential vanilloid 1 (Trpv1) channel, as recently reviewed (Yudin and
Rohacs, 2018). Associated transcripts were most significantly upregulated in TH+ expressing neurons in
the SUPP vs. WT contrast (Figure S5D). These results indicate a positive association between G-protein-
coupled receptor transcripts and vitE deficiency, especially in TH+ DRGNs.
Transcripts for GO-Slim biologic processes known to regulate mitochondrial functions were significantly
(PFDR< 0.05) downregulated in TH+ and NP1 DRG subpopulations (Table S7). This discovery prompted
further evaluation of transcripts associated with oxidative phosphorylation. Between 30% and 50% of the
transcript of mitochondrial complex I, NADH:ubiquinone oxidoreductase supernumerary subunits
(NDUF) were significantly downregulated (PFDR< 0.05) in NP1 and TH2 DRG subpopulations with vitE defi-
ciency (Figure S5E, Table S8).
DISCUSSION
Although the antioxidant role of vitE is well established, with evidence to support protection of critical
fatty acids during development of the nervous system (Miller et al., 2012; Lebold et al., 2013), the proposediScience 21, 720–735, November 22, 2019 729
non-antioxidant roles for this vitamin remain unclear (Gohil et al., 2010; Azzi, 2007). Additionally, it remains
unclear why, although all central nervous system tissues are a-TOH deficient in the Ttpa/mouse model,
the primary clinicopathologic lesions are localized to sensory tracts. Based on the phenotype associated
with AVED (Gotoda et al., 1995; Yokota et al., 1996) and recapitulated in the Ttpa/mouse model (Yokota
et al., 2001; Finno et al., 2018), we expected a profound shift in the transcriptomic profile of the propriocep-
tive DRGN subpopulation. Unexpectedly, we instead identified the most pronounced message alterations
in NP1 and TH+ DRGNs, responsible for mechanosensation. Both NP1 and TH+ DRGNs are small to me-
dium in diameter and unmyelinated, whereas proprioceptive DRGNs are large-diameter myelinated neu-
rons. Intriguingly, both NP1 and TH+ subpopulations of DRGNs arise from the same developmental line-
age for C-fibers, separating into distinct lineages by E16.5–17.5 in the mouse (reviewed in Olson et al.,
2016).
Upregulation of intermediate voltage-gated Ca2+ and K+ channels in SUPP vs. DEF groups (Figure 2)
prioritized the TH+ DRGN subpopulation for further evaluation. Within TH+ DRGNs, Ca2+ dysfunction
with vitE deficiency was implicated by upregulation of the Cav2.3 (Cacna1e) and the Ca
2+-activated K+
channel subunit Kcnmb2 (Figure 3). These findings, in combination with decreased IP3R1 (Figure S3A)
and upregulation of Gq-coupled receptor pathways responsible for the formation of inositol 1,4,5
triphosphate (IP3) (Figures S5B and S5C) in DEF mice, indicate that abnormal Ca
2+ dynamics in TH+
DRGNs may be central to the etiology of AVED. Additionally, downregulation of Car8 (Figures 1C
and S3B), a major inhibitor of IP3R1 (Hirasawa et al., 2007; Hirota et al., 2003), indicated coordinated
transcriptional changes that could contribute to overactive Ca2+ signaling in TH+ DRGNs. Consistent
with this interpretation was the observation that acute vitE deficiency (4–6 months) reduced membrane
excitability (Figures 4 and 5) and caspase activation (Figure S4), whereas long-term deficiency resulted
in apoptosis of DRGNs (Finno et al., 2018). Supplementation with high-dose a-TOH in DEF mice at
weaning prevented the transcriptomic and biochemical profiles described, partially prevented the elec-
trophysiological abnormalities of TH+ DRGNs, and significantly improved mechanical sensitivity as as-
sessed from the displacement-response curves (Figure 6A) and via the von Frey filament assay (Fig-
ure 3F). As peripheral neuropathy is a clinical feature of AVED (Gotoda et al., 1995; Fogel and
Perlman, 2007), altered Ca2+ signaling within mechanosensitive DRGNs could provide a mechanism
for loss of peripheral sensation.
Collectively, our findings are the first to link TH+ DRGNs with vitE deficiency and AVED. TH+ DRGNs
constitute approximately 10%–15% of all mouse lumbar DRGNs (Brumovsky et al., 2006); are located
in haired skin; and are responsive to brush, pressure, and pinch but not temperature (Li et al., 2016).
In patients with AVED, loss of vibration sense and sensitivity to light touch are the frequently reported
symptoms (Gotoda et al., 1995), as the dorsal column medial lemniscal neuroanatomic tract is targeted
in vitE deficiency (Finno et al., 2018; Yokota et al., 1996). Therefore, we postulate that these symptoms
may be due to impaired excitability and abnormal Ca2+ signaling. Specifically, reduced membrane excit-
ability of mechanosensitive DRGNs could account for the peripheral neuropathy associated with AVED.
Supplemental a-TOH has been demonstrated to improve peripheral neuropathy in AVED patients (Mar-
tinello et al., 1998).
Our findings identify altered Ca2+ signaling in TH+ DRGNs with vitE deficiency, in particular, IP3R1 path-
ways. Upregulation of Ca2+-binding transcripts, the voltage-gated Cav2.3 (Cacna1e) channel, and Ca
2+-
activated K+ channel subunit Kcnmb2 are likely mechanistically interrelated alterations that further
contribute to the neuropathology in TH+ DRGNs. First, electrophysiological recordings showed
enhanced K+ and Ca2+ current densities in small-diameter DRGNs isolated from DEF mice. Second, up-
regulation of GPCRs and downregulation of Car8 support a role of altered GPCR/phospholipase C (PLC)/
inositol triphosphate (IP3) signaling in vitE-deficient TH+ DRGNs. Reactive oxygen species can activate
Gq-coupled receptors, catalyzing the conversion of plasma membrane phospholipid phosphatidylinositol
4,5-bisphosphate (PIP2) by PLC to the intracellular secondary molecules IP3 and diacylglycerol (DAG)
(Servitja et al., 2000; Vaarmann et al., 2010). As vitE remains the most potent inhibitor of lipid peroxida-
tion (Choi et al., 2015; McDougall et al., 2017; Niki, 2014), the protection afforded at the plasma mem-
brane may affect GPCR signaling. The decrease in small-diameter DRGN membrane excitability of DEF
mice may, therefore, result from altered Ca2+ signaling in TH+ DRGNs. In keeping with reduced excit-
ability of DEF DRGNs, the rate of change of membrane voltage at the upstroke phase of APs (dV/dt)
was shallow compared with WT neurons (Figure 4C), which may implicate alterations in Na+ current730 iScience 21, 720–735, November 22, 2019
magnitude and kinetics (Han et al., 2012). Although there were no significantly dysregulated Na+ channel
transcripts in the TH+ DRGNs (Table S4), posttranslational modifications of Na+ channels may have
occurred. Additionally, we cannot determine from this study if the observed effects on membrane excit-
ability are the result of the observed gene expression changes following vitE deficiency or the insufficient
vitE concentrations in the DRGNs. Experiments requiring the addition of exogenous a-TOH to DRGNs
from DEF mice would be required to determine if membrane excitability can be restored with the addi-
tion of vitE. Despite this inability to definitively determine causality, the clinical relevance of these find-
ings indicate that gene expression and membrane excitability changes within the DRGN may underlie
the peripheral neuropathy observed with AVED.
By 12 months of age, apoptosis within most large- and small-diameter DRGNs is evident in DEF mice (Finno
et al., 2018). Increased TUNEL staining of DRGNs in DEFmice is not observed by 6months of age (unpublished
results). In this study, scRNA-sequencing was performed only on viable cells (see Cell count/viability and RNA
quality assurance). Therefore, within the 6-monthDEFmice examined in this study, increased activity of cleaved
caspase-3 and -9 in DEF TH+ DRGNs is likely a proximal mechanism of promoting apoptosis.
Using whole tissue spinal cord homogenate, we previously identified altered nuclear receptor activation
in DEF mice as they aged from weaning to 6 months (Finno et al., 2018). With sufficient vitE, retinoid
orphan-related receptor alpha (RORA)-targeted transcripts were activated in the spinal cord, whereas
insufficient vitE led to the activation of liver X receptor (LXR)-targeted transcripts. This effect was not
observed in whole-tissue spinal cord when simply comparing groups at 6 months of age (WT vs. DEF
vs. SUPP). Similarly, we did not identify upregulation of most previously investigated (Finno et al.,
2018) RORA-targeted transcripts in the DRGNs between SUPP and DEF groups at 6 months of age in
this current study. Comparison of DRGNs subpopulations in WT, DEF, and SUPP experimental groups
between weaning and 6 months of age requires further investigation to fully elucidate the role for
RORA with vitE deficiency.
Elevations in 7-oxygenated cholesterol products have been previously described in both the Ttpa/
(Finno et al., 2018) and atherosclerotic apolipoprotein vitE-deficient mouse models (Rosenblat and Aviram,
2002). Both 7a-hydroxycholesterol and 7-ketocholesterol are inverse agonists for the constitutively active
RORA (Wang et al., 2010). Therefore, we surmise that increased oxysterols suppress constitutive RORA
signaling during vitE deficiency, a hypothesis that has been supported by other studies in both the
Ttpa/ mouse (Gohil et al., 2003, 2004) and the vitE-deficient horse (Finno et al., 2016). RORA activation
is required for synaptic maintenance (Landis and Sidman, 1978; Sotelo and Changeux, 1974) and the neuro-
protective effect is mediated by the antioxidant proteins glutathione peroxidase 1 and peroxiredoxin 6
(Boukhtouche et al., 2006). Of note, RORA controls the expression of IP3R1 (Gold et al., 2003; Sarachana
and Hu, 2013). Therefore, the underlying molecular mechanism whereby vitE deficiency leads to AVED
may involve differential nuclear receptor activation with age, leading to altered IP3R1 signaling in TH+
DRGNs, in addition to alterations in redox status at the plasma membrane (Figure 7). Alternatively, specific
oxidized polyunsaturated fatty-acid-derived lipid mediators, which are protected by vitE from oxidation
and destruction (Choi et al., 2015; Lebold et al., 2013; Lebold and Traber, 2014; Ulatowski and Manor,
2013), may be involved in this protective mechanism.
Single-cell RNA-seq generated a total of 382 million reads in our study, with an average of 3,614 DRGNs
profiled per mouse (i.e. 7,228 neurons per experimental group). In the pioneer scRNA-seq study of DRG,
pooled lumbar DRG were used to generate 2.76 billion reads across 622 single mouse neurons (Usoskin
et al., 2015). A total of 3,574 G 2,010 distinct genes were identified in each cell (Usoskin et al., 2015), as
compared with our study of 1,788G 283 genes per cell. A subsequent publication used neuron-size-based
hierarchical clustering and high-coverage scRNA-seq of 203 neurons collected from lumbar DRG of five
pooled male mice (10,950 G 1,218 genes per neuron) (Li et al., 2016). Despite the overall lower depth of
sequencing across genes in our study, we were able to identify the previously characterized (Usoskin
et al., 2015) neuronal subpopulations within the DRG. Previous reports (Usoskin et al., 2015; Li et al.,
2016) clustered the unmyelinated TH+ neuronal population into one population. In our dataset, two
distinct TH+ subgroups (TH1 and TH2) were identified across all samples. Despite highly overlapping tran-
scriptional profiles, these subtypes were not closely enough related to merge, unlike the PEP1 subpopu-
lation (i.e. Clusters 0 and 2). The distinct sub-clustering of TH+ subpopulations in our study warrants further
investigation, as the most profound alterations with vitE deficiency in our model occurred primarily in theiScience 21, 720–735, November 22, 2019 731
Figure 7. Proposed Mechanism of Action for a-TOH in TH+ DRGN
With adequate a-TOH (left), constitutive activity of the RAR-related orphan receptor alpha (RORA) transcription factor is
maintained, increasing IP3R1 transcription (Gold et al., 2003; Sarachana and Hu, 2013). Although there is evidence that
vitE can affect the plasma membrane structure and bind to signaling enzymes to affect their activity (Zingg, 2015;
Habermehl et al., 2005), we propose in this model that signaling through the PLC/IP3/IP3R1 axis maintains Ca
2+
homeostasis. VitE can suppress PLC activity (Domijan et al., 2014) and, by stimulating DAGK (Koya et al., 1997), DAG is
removed and PKC inhibited, providing a protective effect. With a-TOH deficiency (right), cholesterol is oxidized and
resulting oxysterols repress constitutive RORA activity (Wang et al., 2010), leading to decreased IP3R1 transcription. ROS
activate the PLC/IP3/IP3R1 axis (Servitja et al., 2000; Vaarmann et al., 2010); however, without sufficient IP3R1, [Ca
2+]i
cannot increase. Additionally, loss of DAGK stimulation increases DAG and PKC. We propose this leads to the
identified alterations in membrane excitability and activation of apoptotic pathways in DRGNs. BK= big potassium
channel; DAG = diaglycerol; DAGK= diaglycerol kinase; IP3 = inositol triphosphate; IP3R1 = inositol 1,4,5 triphosphate
receptor 1; PIP2 = phosphatidylinositol 4,5-bisphosphate; PKC = protein kinase C; PLC = phospholipase C; RORA= RAR-
related orphan receptor alpha; ROS = reactive oxygen species.TH2 subpopulation. Our mice were 6 months of age, older than those used in previously reported scRNA-
seq profiling studies in DRG (Li et al., 2016; Usoskin et al., 2015).
The von Frey filament assay is used on glabrous skin, which is innervated by both alpha and beta low-
threshold mechanoreceptors, both not TH+ C-low threshold mechanoreceptors (Li et al., 2011). However,
it has been observed that von Frey filament can activate sensitized non-peptidergic type C nociceptive fi-
bers (i.e. NP1 subpopulations) under certain conditions (Pinto et al., 2019). In our study, the NP1 subpop-
ulation, responsible for neuropathic pain, was also notably implicated with vitE deficiency. VitE has been
demonstrated to act as an analgesic in rodent models of neuropathic pain (Kim et al., 2006), although a
more recent study suggests that vitC is required concurrently (Lu et al., 2011). Foot withdrawal thresholds
in response to mechanical stimuli were used to assess neuropathic pain followed by spinal cord ligation,
with increased thresholds for 6 h after vitE injection (Kim et al., 2006). As neurobehavioral assays through
tactile stimuli cannot reliably differentiate different DRGN activities (Li et al., 2011), we elected to document
electrophysiological dysfunction in TH+-specific mechanosensitive DRGNs with vitE deficiency using
whole-cell membrane recordings specific to small-diameter mechanosensitive DRGNs. However, further
investigation into the role of vitE in NP1 nociceptive DRGNs is warranted.
One of the most notable findings identified in the DEFmouse model is the complete prevention of the clin-
ical and histologic phenotype with high-dose a-TOH supplementation at weaning (Finno et al., 2018; Yo-
kota et al., 2001). To further support these clinical findings, we have now demonstrated complete preven-
tion of the transcriptomic and partial rescue of the electrophysiologic dysfunction within the DRGNs at the
single-cell level. VitE supplementation in Ttpa/ mice suffices to partially restore K+ and Ca2+ current
properties in small-diameter mechanosensitive DRGNs, but it remains unclear why slow-adapting DRGNs
are impervious to vitE supplementation. Of note, a-TOH concentrations in the brain of these SUPPmice are
still significantly lower than those ofWTmice (Finno et al., 2018; Yokota et al., 2001), indicating that a-TTP in
the brain functions in maintaining local concentration of a-TOH. Despite the lower brain a-TOH concentra-
tions in SUPP mice compared with WT mice, the AVED clinicohistologic phenotype is completely732 iScience 21, 720–735, November 22, 2019
prevented. Therefore, a minimum concentration of vitE is likely required at this critical time in postnatal
development. Even more important is the fact that the phenotype is rescuable when vitE is provided at
P21, a time point that is considered the end of postnatal development in the mouse. Therefore, it may
be possible that synaptogenesis and axonal elongation continue into adulthood, thereby requiring suffi-
cient vitE from 1–6 months of age in mice.
Although this study focused on DRGNs, vitE has been demonstrated to have effects in other regions of the
nervous system. Within the hippocampus, a-TOH induced long-term potentiation (Xie and Sastry, 1993),
which is involved in learning and memory (Thompson, 1986). The action of vitE in hippocampal CA1 neu-
rons occurred without a significant alteration in the membrane potential and the input resistance. Rats that
are fed a vitE-deficient diet for three months had impaired long-term potential induction, with a reduction
in post-tetanic potentiation, suggesting that either neurotransmitter release or postsynaptic mechanisms
are involved (Xie and Sastry, 1995). It remains to be determined if the postulated mechanism for the neuro-
protective effect of vitE in the DRG (Figure 7) is applicable to other regions of the nervous system.
In conclusion, we have identified the most profound transcriptomic, biochemical, and electrophysiologic
changes in small-diameter TH+ mechanosensitive DRGNs, rather than the proprioceptive subpopulation,
with vitE deficiency. Increased upregulation of voltage-gated Ca2+ and K+ channels led to AP abbreviation
and reduced membrane excitability in TH+ DRGNs. Concurrently, alterations in IP3R1 expression were identi-
fied, in addition to evidence of apoptosis via caspase-3- and caspase-9-mediated pathways. A highly supple-
mented a-TOH diet rescues the cellular andmolecular alterations and represses the loss of mechanosensation
found in DEFmice. The peripheral neuropathy associated with AVED likely encompasses defects in membrane
properties and Ca2+ signaling inmechanosensitive TH+DRGNs, providing targets for therapeutic intervention.
Limitations of the Study
We cannot determine from this study if the observed effects on membrane excitability are the result of the
observed gene expression changes following vitE deficiency or the insufficient vitE concentrations in the
DRGNs. Experiments requiring the addition of exogenous a-TOH to DRGNs from DEF mice would be
required to determine if membrane excitability can be restored with the addition of vitE.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.10.064.
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Figure S1, related to Figure 1A: Principal component analysis identified no difference in 
neuronal clustering between experimental groups.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2, related to Figure 1A: (A) Classification of DRG subpopulations based on previously 
reported gene expression profiles (Li et al., 2016; Usoskin et al., 2015).  NF=neurofilament, 
NP=non-peptidergic, PEP=peptidergic, TH=tyrosine hydroxylase, UNASSIGNED=unassigned 
cluster, n=2 mice per group with ~3,600 cells/mouse profiled. (b) Cluster dendogram used to 
determine subpopulations. Clusters 0 and 2 were merged into Cluster 0.2 based on shared 
peptidergic neuronal cell markers. (C) A distinct subpopulation of microglia cells, using 
previously identified transcriptional markers, was not identified in this dataset (Li et al., 2016; 
Usoskin et al., 2015).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3, related to Fig. 1C: Triple-labeling identified decreased (A) IP3R1 (Itpr1) and 
decreased (B) Car8 protein expression in tyrosine hydroxylase positive DRGN with vitE 
deficiency. Red: IP3R1 (Itpr1) (A) or Car8 (B); Green: Th, Blue: DAPI nuclei. Fluorescent 
immunohistochemistry from 4-month WT, DEF, and SUPP mice. 20x=50 m, 40x=20 m, 
60x=20 m  
 
 
 
 
 
 
 
 
Figure S4, related to Fig. 7: Apoptosis of TH+ DRGNs with vitE deficiency. (A) Heat maps, 
plotted by –logPadjusted , comparing the degree of upregulation for apoptotic transcripts in DRGN 
subpopulations with α-TOH deficiency, with the most significantly upregulation in the Th2 
subpopulation. Contrast A= SUPP vs. WT, contrast B= WT vs. DEF, contrast C= SUPP vs. DEF. 
Aifm3=apoptosis-inducing factor, mitochondrion-associated, Tnfrsf21=tumor necrosis factor 
receptor superfamily, member 21. Triple-labeling identified (B) increased cleaved caspase 3, (C) 
increased cleaved caspase 9 and (D) unchanged cleaved caspase 8 in TH+ DRGN with vitE 
deficiency. Green: Th, Blue: DAPI nuclei. Red: (B) Cleaved caspase 3, (C) Cleaved caspase 9 
and (D) cleaved caspase 8. White box inset magnified in last column. Fluorescent 
immunohistochemistry from 4 month WT, DEF, and SUPP mice. Scale bars= 10 m (TH, 
Cleaved Cas3, Cas9, Cas 8 and merge) and 3 m (enlarged; last column). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure S5, related to Fig. 1: Upregulation of Ca2+ binding transcripts and G-protein 
signaling pathways and downregulation of mitochondrial complex I transcripts in TH+ 
DRGNs with vitE deficiency. Heat maps, plotted by –logPadjusted , comparing the degree of 
upregulation for (A) selected Ca2+ binding transcripts in DRGN subpopulations with vitE 
deficiency. Representative Panther Pathway overrepresentation analysis (red=Mus musculus 
database, blue=overrepresented pathways of the SUPP vs WT groups) from the (B) TH1 and (C) 
TH2 subpopulations demonstrating upregulation of G-protein signaling pathways and G-protein 
coupled receptors (GPCRs). These pathways were identified as upregulated in 9/13 DRGN 
subpopulations (additional figures; Figure S6). (D) Heat maps, plotted by –logPadjusted , 
comparing the degree of upregulation for selected G-protein coupled receptor genes and the 
transient receptor potential vallinoid (Trpv1) channel in DRGN subpopulations with vitE 
deficiency. Contrast A= SUPP vs. WT, contrast B= WT vs. DEF , contrast C= SUPP vs. DEF. 
(E) Percent of mitochondrial complex I: NADH:ubiquinone oxidoreductase supernumerary 
subunits (NDUF) downregulated in DRGN subpopulations with α-TOH deficiency. The most 
pronounced downregulation was within the NP1 (34%) and TH2 (47%) subpopulations. 
Cacna1e= Cav2.3 intermediate voltage-activated Ca2+ channel, Cnr1=cannaboinoid receptor 1, 
Efcab1=EF-hand calcium binding domain 1, Grm=metabotropic glutamate receptor 5, 
Hrt1f=5HT receptor 1f, Kcnj3= GIRK1, Kcnmb=Potassium large conductance calcium-activated 
channel, subfamily M, beta, Npy2r=NPY receptor 2, Pvalb=parvalbumin, S100a11=S100 
calcium-binding protein A11, Scgn=secretagogin. 
 
 
 
  
 
Figure S6, related to Fig. 1:  Representative Panther Pathway overrepresentation analysis 
results of the SUPP vs DEF groups from the other DRG subpopulations, demonstrating 
upregulation of G-protein signaling pathways in a total of 9/13 DRG subpopulations (TH+ 
subpopulations in Figs 2D,E). 
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Tables S1, S4 and S7 are separate Excel files due to size 
 
 
 
 
 
 
 
 
Table S2, related to Fig. 1: Number/name of top genes defining each dorsal root ganglia (DRG) subpopulation  
DRG subpopulation 
# of genes 
defining each 
subpopulation  
Median # 
of cells 
sequenced  
Top transcripts defining neuronal subgroups 
PEP1 (peptidergic 1)  
139 1098 Calca, Tac1, Kit, Ntrk1, Gal, Adcyap1, Gfra3 
Peptidergic nociception 
PEP2 (peptidergic 2)  
82 141 
Ntrk1, Nefh, Cntnap2, Kit, 
Peptidergic nociception Calca, Fam19a1 
NP1 
92 465 
Mrgprd, Lpar3, Calca, Plxnc1, Scg3, Ctxn3, 
Gfra2 
Non-peptidergic nociception 
NP2 
63 102 
Mrgpra3, Ntrk1, Calca, Plxnc1, Adora2b, 
Cbln1 
  Non-peptidergic nociception 
NP2-2 
25 169 Crip1, Kcnmb1, Calca, Emp3 
Non-peptidergic nociception 
NP3 
187 328 Osmr, Sst, Il31ra, Cysltr2, Nppb, Nts 
Non-peptidergic nociception 
NF1 (neurofilament 1) 
72 113 Necab2, Ntrk2, Cacna1h, Ldhb, Nefh, Htr1d 
Low threshold mechanoreceptors 
NF2 (neurofilament 2)  
168 124 Nefh, Ntrk2, Ntrk3, Calb1, Ldhb, Ret 
Low threshold mechanoreceptors 
NF3 (neurofilament 3)  
59 96 Nefh, Fam19a1, Ntrk3, Ldhb, S100b, Tuba4a 
Low threshold mechanoreceptors 
NF4-5 (neurofilament 4-5) 
 
Proprioception 
196 107 
Pvalb, Cntnap2, Spp1, Nefh, Cntnap2, Nxph1, 
Ldhb 
 
TH1 (tyrosine hydroxylase) 
102 380 Th, Piezo2, Slc17a8, Gfra2, Zfp521 Type C low-threshold 
mechanoreceptors 
TH2 (tyrosine hydroxylase) 
254 317 Th, Piezo2, Slc17a8, Gfra2, Zfp521 Type C low-threshold 
mechanoreceptors 
Unassigned 106 52 N/A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cluster# ClusterName #DETs  DOWNREGULATED (Panther) UPREGULATED #DETS DOWNREGULATED (Panther) UPREGULATED #DETs DOWNREGULATED UPREGULATED
0.2 PEP1 228 62 166 65 14 51 465 143 322
1 NP1 463 78 385 154 56 98 1801 795 1006
3 TH1 249 33 216 95 33 62 520 64 456
4 NP3 391 75 316 92 35 57 787 113 674
5 TH2 398 77 321 122 59 63 1138 386 752
6 X 219 15 204 71 33 38 474 101 373
7 PEP2 66 11 55 21 2 19 186 34 152
8 NF2 53 10 43 48 12 36 495 231 264
9 NF4/5 54 3 51 43 9 34 343 88 255
10 NF1 114 14 100 59 12 47 314 63 251
11 NP2 273 7 266 110 42 68 535 62 473
12 NF3 88 15 72 52 7 45 333 107 226
13 Unassigned 192 22 170 100 13 87 424 44 380
Table S3, related to Fig. 1: Number of differentially expressed transcripts (DETs) per DRG subpopulation within each contrast. Experimental groups defined in Transparent Methods
WT vs. DEF SUPP vs. WT SUPP vs. DEF
 PEP1 PEP2 NP1 NP2 NP2-2 NP3 NF1 NF2 NF3 NF4/5 TH1 TH2 Un
L-type ("Long-lasting") Cacna1c X X X
P-type ("Purkinje") Cacna1a
N-type ("Neural" Cacna1b X
R-type ("Residual") Cacna1e X X X X X X X X X
Cacna1h X X X
Cacna1l X X X X X X X
Itpr1
Itpr3
Ryr2 X X X X X X
Ryr3
Two-pore channel Tpcn1
Cation channels of sperm Pkd2
OraI1
OraI2
OraI3
Kcnmb1 X X
Kcnmb2 X X X X X
Kcnk2 X X X
Kcnk3 X X X X
Kcnk12 X X
Kcnk18 X X X X X
Kncj2 X X X X X X
Kcnj3 X X
Kcnj4 X X X X
Kcna2 X X X
Kcnab1 X X X X
Kcnb2 X X
Kcnc1 X X X X X
Kcnc2 X X X X X X
Kcnc4 X X X X
Kcnd2 X X X X
Kcnd3 X X
Kcnh2 X X X
Kcnq2 X X
Kcnq3 X X X
Kcnq5 X X
Kcns1 X X X
Kcns3 X X X
Kcnv1 X X X X X X
Table S5, related to Fig. 2: Differentially expressed transcripts associated with Ca
2+
 and K
+
 channels that passed PFDR < 0.05 across the DRG subpopulations
K
+ 
voltage-gated channel
 Ligand-gated Ca
2+
 channels
IP3 receptor
Ryanodine receptor
Store-operated channels
Ca
2+
-activated K
+
 channels
K
+ 
two-pore domain subfamily K
K
+ 
voltage-gated channel subfamily 
J (inward rectifying  K
+
 channels)
 Voltage-gated Ca
2+
 channels
Type-type ("Transient")
K
+
 channels
 PEP1 PEP2 NP1 NP2 NP2-2 NP3 NF1 NF2 NF3 NF4/5 TH1 TH2 Un
Cbln1 X X X X
Cbln2 X X X X X X
Sema4c X X
Sema5a X X X X X
Sema6a X
Sema7a X X X X
Slc17a6 X X
Slc17a7 X X
Slc17a8 X X X X X X
Unc5a X X X X
Unc5b X X X
Unc5c X X X
Unc5d X X X X X
Unc13c X X
Bdnf – neuronal survival 
and differentiation
X X
Btbd3 – directs dendrites 
toward active axon 
terminals
X X
Dpsyl2 - axonal 
guidance
X X
Kif21a – kinesin family 
axonal transport
X X
Ntrk1 –  tyrosine kinase 
receptor involved in 
axonal extension
X X X X X X
Rtn4r – axonal growth 
inhibition
X X
Slit2 – axonal navigation X X X X X X X
Cplx2 – complexin 2 
formation of synaptic 
vesicle clustering
X X
Stxbp6 – syntaxin 
binding protein
X X X X X X
Sv2a – synaptic vesicle 
glycoprotein
X X X X
Sv2b – synaptic vesicle 
glycoprotein
X X X X
Syt3 – synaptotagmin III X X X X
Syt16 – synaptotagmin 
XVI
X X X X
Sytl3 – synaptotagmin-
like III 
X X X X
Mbp – myelin binding 
protein
X X X X
X 
(Down)
Omg – Oligodendrocyte 
myelin glycoprotein
X X X X X
Table S6, related to Fig. 1: Differentially expressed transcripts associated with synaptogeneis, axonal growth and myelination that passed PFDR < 0.05 across the DRG subpopulations
Synaptic vesicle 
Myelination
Cerebellin precursor proteins 
synapse integrity and plasticity
Sema domain– normal brain 
development, axon guidance and cell 
migration
Solute carrier family 17 –uptake of 
glutamate at presynaptic nerve 
terminals
Unc-5 homology A – receptor for 
netrin required for axon guidance
Axonal growth and extension
 PEP1 PEP2 NP1 NP2 NP2-2 NP3 NF1 NF2 NF3 NF4/5 TH1 TH2 Un
Ndufa9 X X
Ndufa10 X
Ndufa11 X X X
Ndufa12 X X
Ndufa13 X
Ndufab1 X X
Ndufaf2 X
Ndufaf3 X X
Ndufaf6 X
Ndufaf7 X X
Ndufb2 X X
Ndufb3 X
Ndufb4 X
Ndufb6 X X
Ndufb8 X
Ndufb9 X
Ndufb11 X
Ndufc1 X X
Ndufs2 X X
Ndufs3 X X
Ndufs4 X X
Ndufs5 X X
Ndufs6 X
Ndufs7 X X
Ndufs8 X X
Ndufv1 X
Ndufv3 X
Table S8, related to Fig. 1: Differentially expressed transcripts of the mitochondrial complex I:NADH:ubiquinone oxidoreductase supernumary subunits (NDUF)
Transparent Methods 
Contact for Reagent and Resource Sharing 
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Carrie J. Finno (cjfinno@ucdavis.edu). 
 
Reagents for scRNA-seq preparation 
Growth medium for primary DRG cell culture consisted of five components that 
included: 500 mL nutrient mixture F-12 with phenol red stored at 4oC (Gibco™ Ham’s F-12 
Nutrient Mix), 5 mL Penicillin/Streptomycin stock (100 U/mL), 5 mL 100X N2 supplement, 10 
mL 50X B-27 supplement, and 50 mL FBS (10% v/v). Stock solution (15% w/v) was prepared 
using 1.5 g of BSA (Sigma-Aldrich, St. Louis, MO) in 10 mL of F-12 medium. The same BSA 
lot number was used for WT, DEF and SUPP groups. The solution was placed in a 37°C water 
bath to dissolve BSA further. The F-12 medium was filter-sterilized (using a 40μm Flowmi™ 
Cell Strainer) and made into a final solution using a 12 mL syringe/filter. The solution was made 
the day of DRG cell processing. Stock solution (12.5 mg/mL; 1.25% w/v) was prepared by 
placing 50 mg collagenase IV in 4 mL F-12 (no phenol red) and was sterilized by a 0.22 µm 
filter. When resecting the DRG cells, 200 μL of collagenase IV (Gibco™ 17104019) was added 
to 1.8 mL HBSS (Hank’s Balanced Salt Solution). 
 
Experimental model and subject details 
Mice 
Animals were housed and cared for under the University of California Davis (UCD) and 
University of Reno (UNR) standing committee on animal use and care (IACUC) as well as the 
Guide for the Care and Use of Laboratory animals (8th edition, 2011). All procedures performed 
were also approved by the University (UCD and UNR) IACUC. A rederived colony of mixed 
(50% C57BL6 and 50% 129/SvJae) mice heterozygous for the deletion (Ttpa+/-) were crossed 
with C57BL6/J (Ttpa-/-) mice to establish a colony of Ttpa-/- mice. Offspring were genotyped 
using specific primers for Ttpa, and genotypes confirmed by western blot analysis of hepatic 
TTP using an anti-TTP antibody as previously described (Terasawa et al., 2000). 
At weaning, Ttpa+/+ mice were fed a normal diet (35 mg of dl-α-tocopheryl acetate/kg, 
vitE+; WT) while Ttpa-/- mice were fed either an α-TOH-deficient diet (<10 mg of dl-α-
tocopheryl acetate/kg, vitE-; DEF), or α-TOH-supplemented diet (600 mg of dl-α-tocopheryl 
acetate/kg, vitE+++; SUPP) diet. Custom Teklad non-irradiated vacuum-packaged diets were 
ordered through Harlan Laboratories (Madison, WI) and were identical to those previously used 
in this mouse model (Finno et al., 2018, Ulatowski et al., 2014). To prevent oxidation, diets were 
maintained at -20°C and used within six months. Mouse diets were replaced once per week, and 
high-performance liquid chromatography with fluorescence detection used to confirm dietary α-
TOH concentrations was performed as previously described (Finno et al., 2018).   
 
Method Details 
Neurobehavioral assessment 
Examination of mechanical sensation was performed on mice at 6 months of age, when 
the onset of ataxia are first noticeable (Finno et al., 2018). Mice were housed under conditions of 
constant temperature (20°C), light (6:00 am to 6:00 pm), and with access to food and water ad 
libitum. Testing apparatus was cleaned with 70% ethanol to remove animal odors before and 
after each test. Experiments were performed with 8-15 mice per group, consisting of ~50% male 
and 50% female. Each test was performed at one time point, 1-2 days before sacrifice. The von 
Frey filament assay was performed as previously described (Martinov et al., 2013). Mice were 
habituated to the experimental environment for at least 30 minutes. Briefly, von Frey filaments 
of increasing stiffness (0.008-1.4g) were applied on both hind paws planter surface with enough 
pressure to bend the filament, to determine the stimulus intensity threshold stiffness required to 
elicit a paw withdrawal response. A total of six recordings were performed per mouse (initial 
reflex, followed by five “up-down” stimuli). Dixon’s score was calculated as previously 
described (Dixon, 1965). 
 
Dorsal root ganglion neuron (DRGN) isolation 
At 5-6 months of age, one male and one female mouse were sacrificed with pentobarbital 
(>100 mg/kg IP). After euthanasia, the spinal column was removed by making lateral incisions 
on both sides. The spinal cord was then severed at the C1 (cervical) and L6 (lumbar) vertebrae. 
The dorsal portion of the spinal column was removed, exposing the spinal cord. Shortly after, the 
spinal cord was removed to expose the DRG. Dorsal root ganglia were extracted using micro 
dissecting forceps and microscissors. Dorsal root ganglia were placed in a petri-dish containing 
1.8 mL of ice-cold HBSS. The spines of the dorsal root ganglia were trimmed using 
microdissection scissors.  
Following DRG removal, 200 μL of collagenase was added to the HBSS solution 
containing the DRG. The whole DRG were placed in an incubator for 2 hours at 37oC, 5% CO2. 
The DRG were subsequently transferred to a 15 ml conical centrifuge tube and washed twice 
with 10 mL of pre-warmed growth medium to remove any remaining collagenase solution. 
Collagenase is inhibited by cysteine, which is a component of the F-12 nutrient mix. The 570 mL 
stock solution of growth medium contained 500 mL F-12, 5 mL Pen/Strep, 5 mL 100X N2 
supplement, 10 mL 50X B27 supplement, and 50 mL FBS. While in the 15 mL conical tube, 
DRG were triturated to dissociate the DRG into individual cells. Afterward, the volume was 
aspirated and filtered through a 40-μm FlowmiTM Cell Strainer. The cell suspension was slowly 
dripped onto 10 mL 15% BSA (bovine serum albumin), pre-warmed growth medium in a 15 mL 
conical tube and centrifuged at 200 x g for 20 minutes. The BSA stock solution contained 1.5 g 
of BSA dissolved in 10 mL of F-12. The supernatant was aspirated, leaving approximately 20 μL 
covering the cell pellet. In this protocol, nerve growth factor (NGF) was not used in the growth 
medium as NGF alters gene expression (Lindsay and Harmar, 1989). 
 
Cell count/viability and RNA quality assurance  
A hemocytometer was used to determine the viability of the cells stained with trypan 
blue. Once non-neuronal cells were removed using a 10 mL 15% BSA treatment and centrifuged 
at 200 x g, a portion of the cell suspension was aliquoted into a 0.5 mL microcentrifuge tube. 
Despite this treatment, some non-neuronal cells may survive the removal process. Depending on 
the volume of the cell suspension, a 1:1 mixture was made using 0.4% trypan blue solution. The 
mixture was pipetted into the V-shaped groove of the coverslip. The viable and non-viable cells 
in each of the four corner quadrants were multiplied by 104. To obtain the percentage of viable 
cells, the following formula was used: % viable cells= [1.00 - (# of nonviable cell / # of total 
cells)] x 100. Samples were analyzed on an Agilent Bioanalyzer before and after library 
preparation to ensure quality RNA and cDNA was sequenced.  
 
Single-cell RNA-sequencing 
 Barcoded 3' single-cell libraries were prepared from single-cell suspensions using the 
Chromium Single Cell 3' Library and Gel b ead kit v2 (10X Genomics, Pleasanton, California). 
Libraries were pooled and sequenced on an Illumina HiSeq4000 with pair-end 100 bp reads. 
Cellranger v.2.0.1 and bcl2fastq v.2.17.1.14 commands mkfastq and count were used to generate 
fastq files per sample, align to mm10, filter, and perform barcode and UMI counting. Analyses 
were conducted in R, version 3.4.4 (Team, 2018). Normalization, clustering, and calculation of 
TSNE (van der Maaten and Hinton, 2008) coordinates were conducted using Seurat, version 
2.3.0 (Satija et al., 2018). Differential expression analyses between treatments, adjusting for 
sample and sex, were conducted on the filtered and normalized data using limma, version 
3.32.10 (Ritchie et al., 2015). Pathway analyses were performed using Panther Pathway 
overrepresentation analysis (http://pantherdb.org/). 
 
Single-molecule fluorescence in situ hybridization (smFISH) with RNAscope 
Mice were anesthetized with an intraperitoneal injection of ketamine (100 mg/kg) and 
xylazine (10 mg/kg), and were transcardially perfused with diethyl-pyrocarbonate (DEPC)-
treated phosphate buffer saline (PBS) and 4% paraformaldehyde (PFA) to preserve RNA. Dorsal 
root ganglia (DRG) were extracted using micro dissecting forceps and micro-scissors. Dorsal 
root ganglia were placed in a petri-dish containing 1.8 mL of ice-cold DEPC-treated PBS. The 
tissues were trimmed using a surgical scalpel blade and were kept in a 4% PFA in DEPC-treated 
solution, overnight on a shaker at 4°C. Samples were sequentially dehydrated in 10%, 20%, and 
30% sucrose solution at 4°C for 1 hr, 2 hr, and overnight, respectively. Samples were transferred 
into optimal cutting temperature (OCT) compound for a minimum of 1 hr at 4°C and then snap 
frozen, using a dry ice-ethanol mixture. Samples were cryo-sectioned to a thickness of 14 μm, 
placed onto Superfrost slides and stored at -80°C until processed. 
 
Probe hybridization and immunofluorescent staining  
Probe hybridization was performed according to the manufacturer’s instructions 
(Advanced Cell Diagnostics, ACD). Sections were immersed in pre-chilled 4% PFA for 15 min 
at 4°C. Sections were then dehydrated at room temperature (RT) in 50%, 70% and twice in 100% 
ethanol for 5 min each and allowed to dry for 1-2 min. Fixation and dehydration were followed 
by hydrogen peroxide reaction for 10 min at RT then, protease digestion, using protease 4 for 30 
min at RT. Slides were incubated with probes in 2 hours at 40°C. To amplify and detect signals, 
sections were treated as follows at 40°C: AMP1 for 30 min, followed by AMP2 for 30 min, 
AMP3 for 15 min, the appropriate HRP channel for 15 min, Opal dye for 30 min, and HRP 
blocker for 15 min. Each of these alternated with a washing step two times for 2 min at RT. 
Probes for Kcnmb2, Kcnq3, Kcnv1 and Cacna1e and controls were obtained from ACD. 
Sequences of the target probes and label probe are proprietary. Detailed information about the 
probe sequences can be obtained by signing a non-disclosure agreement provided by the 
manufacturer. 
For subsequent immunofluorescent staining, slides were treated with 10% blocking 
solution for 30 min at RT, incubated with primary antibody (Tyrosine Hydroxylase, LSbio, 1:500 
dilution), overnight at 4°C, washed with TBS-0.005%Tween20 three times for 5 min each, 
incubated with secondary antibody (Alexa 647, Life Technologies, 1:500) for 2 hours at RT, and 
again washed with TBS-0-005% Tween20 three times for 5 min each. Incubation in DAPI 
solution for 30s at RT was performed to label cell nuclei. Slides were then mounted in 
Fluoromount-G and sealed under a coverslip. 
 
Immunofluorescence 
Following microdissection, the tissue was fixed at 4°C in 4% PFA in PBS and 10% and 
30% sucrose at 4°C overnight, then embedded in OCT for cryo-sectioning in the cryo-mold. 
Sections of 10-µm were washed in PBS, permeabilized in 0.1% Triton X-100 for 10 min, and 
then incubated for 60 min in a blocking solution containing 10% goat serum. The sections were 
incubated with primary antibody overnight at 4°C in a humid-chamber. The rinsed sections were 
then incubated (2 hrs; RT) in a fluorescent dye-conjugated secondary antibody. The following 
primary antibodies were used: rabbit anti KCNQ3 (Abcam, #ab16228), rabbit anti KCNV1 
(Abcam, #ab175548), mouse anti KCNMB2 (Abcam, #ab94598), rabbit anti Cav2.3 (Alomone 
Labs, #ACC-006), mouse anti tyrosine hydroxylase (TH; LSBio, #LS-C338121), rabbit anti TH 
(LSBio, #LS-C354112), rabbit anti cleaved caspase-3, -8 and -9 (Cell Signaling Technology, 
#9664, #8592, and #9509), rabbit anti total caspase-3 and -9 (Abcam, #ab13847, and 
#ab202068). Secondary antibodies were Alexa 488-conjugated affinity-purified goat anti-rabbit 
IgG, Alexa 488-conjugated affinity-purified goat anti-mouse IgG, Cy3-conjugated affinity-
purified goat anti-rabbit IgG, Alexa 555-conjugated affinity-purified goat anti-mouse IgG 
(Invitrogen and Jackson Labs). Images were captured with a Nikon A1 confocal microscope. 
 
Isolation of DRGNs for electrophysiological recordings 
Dorsal root ganglion neurons (DRGNs) were isolated from male and female mice from 
each experimental group. Dissected tissue was removed and placed in a solution containing 
Minimum Essential Medium with Hank’s salt (Invitrogen), 0.2 g/L kynurenic acid, 10 mM 
MgCl2, 2% fetal bovine serum (FBS; v/v), and 6 g/L glucose. Tissues were digested in an 
enzyme mixture containing collagenase type I (1 mg/mL) and DNase (1 mg/mL) at 37 °C for 20 
min. After a series of gentle trituration and centrifugation in 0.45 M sucrose, the cell pellets were 
reconstituted in 900 mL culture media (Neurobasal-A, supplemented with 2% B27 (v/v), 0.5 mM 
L-glutamine, 100 U/mL penicillin; Invitrogen) and filtered through a 50-m cell strainer for cell 
culture. DRGNs were cultured for 24 to 48 hrs. All electrophysiological experiments were 
performed at RT (21-22°C). Reagents were obtained from Sigma-Aldrich (St. Louis, MO) unless 
otherwise noted. A stock solution of rSNX-482 was made and (10 mM) stored at -20oC.  
To identify mechanosensitive DRGNs, small-diameter neurons were identified, and 
mechanical stimulation was achieved using a fire-polished and sylgard-coated glass pipette (tip 
diameter ~1-2 μm), positioned at an angle of ~60° to the DRGN being recorded. Downward 
movement of the probe toward the cell was driven by a piezo-electric crystal micro stage (E660 
LVPZT Controller/Amplifier; Physik Instruments). The probe was typically positioned close to 
the cell body without any visible membrane deformation. We assessed for mechanical sensitivity 
using a series of mechanical steps in ~0.42 µm increments applied every 10 to 20 s, which allowed 
for the full recovery of mechanosensitive currents between steps. Inward mechanically-activated 
(MA) currents were recorded at a holding potential of -70 mV. For voltage-clamp recordings of 
MA currents, patch pipettes had resistance of 2-3 MΩ when filled with an internal solution 
consisting of (in mM): 70 CsCl, 55 NMDGCl, 10 HEPES, 10 EGTA, 1 CaCl2, 1 MgCl2, 5 MgATP, 
and 0.5 Na2GTP (pH adjusted to 7.3 with CsOH). The extracellular solution consisted of (in mM): 
130 NaCl, 3 KCl, 1 MgCl2, 10 HEPES, 2.5 CaCl2, 10 glucose and 2 CsCl (pH was adjusted to 7.3 
using NaOH). 
Data analyses were performed using pClamp8 (Axon Instruments) and Origin software 
(Microcal Software, Northampton, MA) offline. The peak mechanically-activated (MA) current 
(IMA) for each step displacement I(X) was expressed in the form of the probability of channel 
opening (Po of I/Imax) with a Boltzmann equation Po = 1/[1 + e
z(X – X
1/2
)/(kT)] to obtain single-
channel gating force, z, and the displacement at 50% open probability (X1/2), and T is 
temperature. 
 
Current-clamp experiments 
Whole-cell membrane potential recordings were performed using an Axopatch 200B 
amplifier (Molecular Devices, San Jose, CA). Membrane potentials were amplified, bandpass 
filtered (2-10 kHz), and digitized at 5-50 kHz using an analog-to-digital converter (Digidata 
1200, Molecular Devices) as described earlier (Levic et al., 2007, Rodriguez-Contreras et al., 
2008). Electrodes (2-3 M) were pulled from borosilicate glass pipettes, and the tips were fire-
polished. Extracellular/bath solution consisted of (in mM) 145 NaCl, 6 KCl, 1 MgCl2, 2 CaCl2, 
10 D-glucose, and 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.3. The 
normal pipette/internal solution contained (in mM) 146 KCl, 1 MgCl2, 0.1 CaCl2, 5 ethylene 
glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA) 4 MgATP, 0.4 NaGTP and 10 
HEPES, pH 7.3. The seal resistance was typically 5-10 G. Data analyses were performed using 
the pClamp and Origin software (MicroCal Inc., Northampton, MA). Where appropriate, pooled 
data are presented as means + S.E.  
 
Voltage-clamp experiments 
Whole-cell voltage-clamp recordings were conducted at room temperature (RT) using an 
Axopatch 200B amplifier and filtered at 2kHz through a low-pass Bessel filter. Data were digitized 
at 0.5-1.0 kHz using a Digi-Data analog-to-digital converter. To study Ca2+ currents in DRGNs, 
after ~2 days in culture, the cells were held in a bath solution (in mM; 60 NMGCl, 50 CholineCl, 
10 NaCl, 20 tetraethylammonium chloride (TEACl), 5 4-Aminopyridine (4-AP), CsCl, 5 CaCl2, 
0.5 MgCl2, 10 HEPES and 5 Glucose at pH 7.4). Freshly reconstituted tetrodotoxin (TTX) (final 
concentration, 2M) was added to the bath solution to further suppression Na+ currents. The 
internal solution contained (in mM) 60 Cs-gluconate, 60 mM N-methyl-d-glucamine (NMDG)-Cl, 
2 MgCl2, 0.1 CaCl2, 5 K2ATP, 0.5 GTP-sodium, 5 EGTA, and 10 HEPES, pH 7.35, with CsOH. 
K+ currents were measured using bath solution containing (in mM: 60 NMGCl, 35 
CholineCl, 5 KCl, 10 NaCl, 0.05 CaCl2, 0.5 MgCl2, 10 HEPES and 5 glucose at pH 7.4). Freshly 
reconstituted tetrodotoxin (TTX) (final concentration, 2M) was added to the bath solution to 
suppression Na+ currents. The pipette solution contained (in mM; 140 KCl, 1 MgCl2, 10 HEPES, 
2.5 EGTA, 1 CaCl2, and 4 MgATP, at pH 7.2). Freshly reconstituted tetrodotoxin (TTX) (final 
concentration, 2M) was added to the external solution to suppression Na+ current when 
measuring K+ and Ca2+ currents. Ca2+ currents were also suppressed, but not eliminated using 
50M external Ca2+ 
Borosilicate glass pipettes were pulled using a Sutter P-97 Flaming Brown Micropipette 
Puller (Sutter Instruments) and fire-polished for an optimal pipette resistance (2-3 MΩ). Access 
resistance was compensated further by at least 80%. After achieving a GΩ-seal, gentle suction was 
applied to form a whole-cell configuration. In all cases, liquid junction potentials were measured 
and corrected as described previously (Rodriguez-Contreras and Yamoah, 2001). Currents were 
activated with depolarizing voltage steps from -120 to 40 mV, using a ∆V of 10 mV and holding 
potentials at -40, -60 and -90 mV. All protocols were employed without online leak subtraction. 
 
Quantification and Statistical Analysis 
Statistical analysis  
All data was evaluated for normality using a Shapiro-Wilk test. Parametric data were 
analyzed via a one-way ANOVA compared the three genotype / diet groups followed by a Tukey 
post-hoc test. Non-parametric data were analyzed with a Kruskal-Wallis test followed by Dunn’s 
multiple comparison tests. For quantification of mRNA via RNA-scope, four high-power fields 
were evaluated from n=2-3 mice in each group and number of mRNA TH+ DRGNs quantified. 
For electrophysiologic recordings, n=2-3 pooled mice with 9-15 DRGNs per experimental group 
were recorded. Significance was set at p <0.05.  
 
Data and Software Availability 
The raw and processed data for scRNA-seq individual libraries have been deposited in 
the NCBI Gene Expression Omnibus (GEO) under ID codes (GEO:GSE128276, GSM3670444, 
GSM3670445, GSM3670446, GSM3670447, GSM3670448, GSM3670449).  
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